El MRHA britanico publica el primer numero de Drug Safety Update este mes de agosto, con el siguiente contenido:
Drug safety advice
- Gadolinium-containing contrast agents and nephrogenic systemic fibrosis.
- Extraneal and products that contain (or are metabolised to) maltose, xylose, or galactose: false glucose reading.
- α1-adrenoreceptor antagonists and intraoperative floppy iris syndrome .
- Cabergoline: risk of cardiovalvulopathy.
- Linezolid: restriction of indication.
- Dopamine agonists and pathological gambling, increased libido, and hypersexuality.
- Antidepressants and risk of suicidal behaviour.
Yellow Card scheme update
Hot topics
- Isotretinoin for severe acne .
- Smoking-cessation aids
0 comentarios:
Publicar un comentario